Monkeypox 2022 outbreak isolate, Human, United Kingdom ex UK
Monkeypox 2022 outbreak strain
Product Risk Group:
Viral Storage Medium -80C
Non cultivable virus sample, infectivity cannot be tested
Nucleic acid material extracted from clinical samples or viral tissue culture. Material has been extracted using a guanidine thiocyanate-based extraction methodology and is likely to contain a mix of purified DNA and RNA (human, animal and/or pathogen derived). Sterility is not assured but residual risk of live biological agents or infectious material present in the sample has been risk assessed as negligible. Use of universal precautions (CL2) recommended.
Virus host type:
Production cell line:
Whole genome sequencing.
Information about the collection of the virus
Biological material origin:
Country of collection:
Suspected epidemiological origin :